Apyx Medical (APYX) Total Non-Current Liabilities (2010 - 2026)

Apyx Medical (APYX) has reported Total Non-Current Liabilities for 17 consecutive years, with $49.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Non-Current Liabilities fell 1.57% year-over-year to $49.6 million; the trailing twelve-month figure through Jun 2026 stood at $49.6 million (down 1.57% YoY), and the FY2025 full-year result was $51.7 million, up 2.81% from the prior year.
• Total Non-Current Liabilities was little changed at $49.6 million in Q2 2026 per APYX's latest filing, from $49.6 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $52.1 million in Q4 2023 and bottomed at $12.9 million in Q3 2022.
• Historically, Total Non-Current Liabilities has averaged $37.7 million across 5 years, with a median of $49.5 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities decreased 5.12% in 2022, then soared 277.65% in 2023.
• Over 5 years, Total Non-Current Liabilities stood at $13.8 million in 2022, then jumped by 277.65% to $52.1 million in 2023, then declined by 3.59% to $50.2 million in 2024, then grew by 2.81% to $51.7 million in 2025, then retreated by 3.9% to $49.6 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $49.6 million, $49.6 million, and $51.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.